ATI RN
Cardiovascular System Exam
1. What type of stroke is caused by a blockage in an artery supplying blood to the brain?
- A. Ischemic stroke
- B. Hemorrhagic stroke
- C. Transient ischemic attack
- D. Embolism
Correct answer: A
Rationale: The correct answer is A: Ischemic stroke. Ischemic stroke occurs when a blood clot blocks an artery supplying blood to the brain, leading to brain damage. Choice B, Hemorrhagic stroke, is caused by bleeding in the brain, not a blockage. Choice C, Transient ischemic attack, is a temporary blockage of blood flow to the brain with symptoms similar to a stroke but typically lasting only a few minutes. Choice D, Embolism, refers to a blood clot or other particle that travels through the bloodstream and blocks a blood vessel.
2. This is a chronic condition where the heart is unable to pump enough blood to meet the body's needs.
- A. Heart failure
- B. Cardiomyopathy
- C. Myocarditis
- D. Pericarditis
Correct answer: A
Rationale: The correct answer is A: Heart failure. Heart failure is a chronic condition characterized by the heart's inability to pump enough blood to meet the body's needs, resulting in symptoms such as fatigue, shortness of breath, and fluid retention. Choice B, Cardiomyopathy, refers to diseases of the heart muscle that can lead to heart failure but is not the specific term for the condition described. Choices C and D, Myocarditis and Pericarditis, respectively, are conditions involving inflammation of the heart muscle or the lining around the heart, which can cause heart failure as a complication but are not the primary condition described in the question.
3. The client is receiving digoxin and has a potassium level of 2.8 mEq/L. What is the nurse’s priority action?
- A. Hold the digoxin and notify the healthcare provider.
- B. Increase the dose of digoxin.
- C. Continue the current dose of digoxin.
- D. Administer potassium supplements.
Correct answer: A
Rationale: The correct answer is to hold the digoxin and notify the healthcare provider. A potassium level of 2.8 mEq/L indicates hypokalemia, which can increase the risk of digoxin toxicity. Holding the medication and informing the healthcare provider is crucial to prevent adverse effects. Choice B is incorrect because increasing the dose of digoxin would further raise the risk of toxicity. Choice C is incorrect as continuing the current dose could exacerbate the toxicity risk. Choice D is incorrect because administering potassium supplements alone is not sufficient to address the potential digoxin toxicity; the first step should be to hold the digoxin and seek further guidance.
4. Which condition is characterized by a chronic cough that produces mucus, often caused by long-term exposure to irritants?
- A. Chronic bronchitis
- B. Tuberculosis
- C. Asthma
- D. Sinusitis
Correct answer: A
Rationale: Chronic bronchitis is the correct answer. It is characterized by a long-term cough with mucus production, often caused by smoking or prolonged exposure to irritants. Tuberculosis (choice B) is a bacterial infection that primarily affects the lungs but does not usually present with a chronic cough as the main symptom. Asthma (choice C) is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to wheezing and shortness of breath, but it does not typically cause chronic mucus production. Sinusitis (choice D) is inflammation of the sinuses and presents with symptoms like facial pain, nasal congestion, and post-nasal drip, but not specifically a chronic cough with mucus production.
5. The client is on spironolactone (Aldactone) and has a potassium level of 5.9 mEq/L. What is the nurse’s priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer potassium supplements.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct answer: A
Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.9 mEq/L is high, indicating hyperkalemia. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, the priority action is to hold the medication to prevent exacerbating hyperkalemia and notify the healthcare provider for further guidance. Choice B is incorrect because administering potassium supplements would worsen hyperkalemia. Choice C is incorrect because continuing spironolactone could lead to a further increase in potassium levels. Choice D is incorrect because increasing the dose of spironolactone would exacerbate the hyperkalemia.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access